Target Price | $155.50 |
Price | $149.76 |
Potential | 3.83% |
Number of Estimates | 22 |
22 Analysts have issued a price target Illumina 2025 . The average Illumina target price is $155.50. This is 3.83% higher than the current stock price. The highest price target is $252.00 68.27% , the lowest is $105.00 29.89% . | |
A rating was issued by 27 analysts: 16 Analysts recommend Illumina to buy, 10 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Illumina stock has an average upside potential 2025 of 3.83% . Most analysts recommend the Illumina stock at Purchase. |
22 Analysts have issued a sales forecast Illumina 2024 . The average Illumina sales estimate is $4.4b . This is 1.68% lower than the revenue of the last 12 months(TTM). The highest sales forecast is $4.4b 0.63% , the lowest is $4.3b 3.45% .
This results in the following potential growth metrics:
2023 | $4.5b | 1.75% |
---|---|---|
2024 | $4.4b | 3.32% |
2025 | $4.6b | 4.69% |
2026 | $4.9b | 7.10% |
2027 | $5.2b | 7.22% |
2028 | $5.5b | 6.02% |
11 Analysts have issued an Illumina EBITDA forecast 2024. The average Illumina EBITDA estimate is $1.2b . This is 27.94% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $1.5b 62.23% , the lowest is $1.0b 9.35% .
This results in the following potential growth metrics and future EBITDA Margins:
2023 | $338m | 54.81% |
---|---|---|
2024 | $1.2b | 248.23% |
2025 | $1.3b | 8.57% |
2026 | $1.4b | 9.98% |
2027 | $1.7b | 19.39% |
2023 | 7.50% | 54.01% |
---|---|---|
2024 | 27.03% | 260.19% |
2025 | 28.03% | 3.70% |
2026 | 28.78% | 2.68% |
2027 | 32.05% | 11.36% |
6 Illumina Analysts have issued a net profit forecast 2024. The average Illumina net profit estimate is $-2.2b . This is 29.23% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $-1.8b 41.65% , the lowest is $-3.4b 11.22% .
This results in the following potential growth metrics and future Net Margins:
2023 | $-1.2b | 73.80% |
---|---|---|
2024 | $-2.2b | 84.57% |
2025 | $585m | 127.12% |
2026 | $719m | 22.94% |
2027 | $831m | 15.48% |
2028 | $933m | 12.38% |
2023 | -25.95% | 73.33% |
---|---|---|
2024 | -49.53% | 90.89% |
2025 | 12.83% | 125.90% |
2026 | 14.73% | 14.81% |
2027 | 15.86% | 7.67% |
2028 | 16.82% | 6.05% |
6 Analysts have issued a Illumina forecast for earnings per share. The average Illumina <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is $-13.57 . This is 29.21% higher than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is $-11.19 41.63% , the lowest is $-21.32 11.22% .
This results in the following potential growth metrics and future valuations:
2023 | $-7.35 | 73.80% |
---|---|---|
2024 | $-13.57 | 84.63% |
2025 | $3.68 | 127.12% |
2026 | $4.52 | 22.83% |
2027 | $5.22 | 15.49% |
2028 | $5.87 | 12.45% |
Current | -7.81 | 90.49% |
---|---|---|
2024 | -11.04 | 41.36% |
2025 | 40.70 | 468.66% |
2026 | 33.11 | 18.65% |
2027 | 28.67 | 13.41% |
2028 | 25.51 | 11.02% |
Based on analysts' sales estimates for 2024, the Illumina stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of 5.92 and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of 5.48 .
This results in the following potential growth metrics and future valuations:
Current | 5.82 | 38.24% |
---|---|---|
2024 | 5.92 | 1.74% |
2025 | 5.66 | 4.48% |
2026 | 5.28 | 6.63% |
2027 | 4.93 | 6.73% |
2028 | 4.65 | 5.67% |
Current | 5.39 | 38.98% |
---|---|---|
2024 | 5.48 | 1.71% |
2025 | 5.23 | 4.48% |
2026 | 4.89 | 6.63% |
2027 | 4.56 | 6.74% |
2028 | 4.30 | 5.68% |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.